HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

BACKGROUND: Cholangiocarcinoma is a rapidly fatal cancer entity with a median survival of less than one year. In contrast to many other malignancies, no substantial therapeutic breakthrough has been made in the past few decades, thereby limiting the treatment to cytotoxic chemotherapy with little be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Albrecht, Thomas, Rausch, Melina, Rössler, Stephanie, Albrecht, Michael, Braun, Jana Dorothea, Geissler, Veronika, Mehrabi, Arianeb, Vogel, Monika Nadja, Pathil-Warth, Anita, Mechtersheimer, Gunhild, Renner, Marcus, Rupp, Christian, Weiss, Karl Heinz, Busch, Elena, Köhler, Bruno, Springfeld, Christoph, Schirmacher, Peter, Goeppert, Benjamin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6896712/
https://ncbi.nlm.nih.gov/pubmed/31805897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6320-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados